MISSISSAUGA,
ON, Nov. 12, 2014 /PRNewswire/
- KP Tissue Inc. ("KPT") (TSX: KPT) reports the Q3 2014 Financial
and Operational Results of KPT and Kruger Products L.P.
(KPLP):
- Revenue increased by 9.8% to $267.6
million in Q3 2014 compared to $243.8
million in Q3 2013
- EBITDA of $38.0 million in Q3
2014, up from $31.1 million in Q3
2013
- Maintained number one overall consumer market share in
Canada
"We are pleased by our solid EBITDA performance
of $38.0 million in the third
quarter, an increase of over 22% compared to last year. The EBITDA
increase primarily reflects higher sales volume in Canada and greater TAD Product contribution in
the U.S.," said Mario Gosselin, CEO
of KP Tissue and KPLP.
"The recent Metro Paper acquisition also
improved the results in the Away-from-Home (AFH) segment. TAD
Products contributed $6.5 million
during the third quarter and we have updated the expected EBITDA
contribution for fiscal 2014 to between $23
million to $25 million, raising the bottom end of the
range.
"Our EBITDA outlook for the fourth quarter is
for year-over-year improvement. Compared to Q3 2014, we expect that
Q4 EBITDA will be reduced due to seasonally higher advertising
expenditures and plant maintenance costs," Mr. Gosselin
concluded.
KP Tissue Inc.
KPT currently holds a 16.5% interest in KPLP. The highlights,
discussion and analysis in this earnings release, unless identified
specifically as representing the financial results of only KPT,
relates entirely to the financial results of KPLP.
KPLP Q3 2014 Financial Results
Revenue in Q3 2014 was $267.6
million, compared to $243.8 in
Q3 2013, an increase of $23.8
million. Revenue increased across all segments and
geographies and was primarily due to the acquisition of Metro Paper
on June 3rd in the AFH
segment. Revenue also increased as a result of higher sales
volume in the Consumer segment in Canada, an increase in TAD Product sales in
the U.S., and the favourable impact of foreign exchange on U.S.
dollar sales.
Cost of sales in Q3 2014 was $219.9 million, compared to $200.7 million in Q3 2013 due to increases in
commodity prices, particularly pulp fibre and natural gas, the
unfavourable impact of foreign exchange, and an increase in freight
expenses related primarily to higher sales volume. These cost
increases were offset somewhat by the favourable mix of products
sold, cost reduction initiatives and timing of maintenance
spending. As a percentage of revenue, cost of sales were 82.2
percent in Q3 2014 compared to 82.4 percent in Q3 2013.
Selling, general and administrative (SG&A)
expenses in Q3 2014 were $17.7
million, compared to $19.7
million in Q3 2013 due to lower advertising and promotion
expenses, partially offset by the impact of a realized loss on
foreign exchange.
EBITDA in Q3 2014 was $38.0 million compared to $31.1 million in Q3 2013, driven by favourable
sales volume and mix resulting from increased sales in the Canadian
Consumer business and in the U.S. for TAD Products and lower
SG&A, as well as incremental EBITDA from the AFH Metro Paper
acquisition. TAD Product EBITDA was $6.5
million in Q3 2014 compared to EBITDA of $1.8 million in Q3 2013.
Net income in Q3 2014 was $16.1 million, compared to $14.2 million in Q3 2013. The increase was
primarily due to the increase in EBITDA of $6.9 million, partially offset by a change in the
amortized cost of the Partnership unit liability of $1.1 million, an unrealized foreign exchange loss
of $2.7 million and higher
depreciation expense as a result of the TAD Project.
The cash balance as of September 28, 2014 was $36.3 million compared to $40.5 million as of June
29, 2014. Cash generated from operating activities resulting
from EBITDA in Q3 2014 and a reduction in pension funding was more
than offset by additional working capital requirements and interest
and debt payments in the quarter.
KPT Q3 2014 Financial Results
- Net income of $0.6 million in Q3
2014
- Earnings per share of $0.08 in Q3
2014
Included in the net income of $0.6 million in Q3 2014 was $2.7 million representing KPT's share of KPLP's
profit. The profit was offset somewhat by depreciation expense of
$1.4 million related to adjustments
to carrying amounts on acquisition, and income tax expense of
$0.8 million.
KPLP Distribution
KPLP will pay a distribution of $0.18
per KPLP unit to its partners on or prior to January 15, 2015.
Dividends on Common Shares
The Board of Directors of KP Tissue Inc. declared a quarterly
dividend of $0.18 per share to be
paid on January 15, 2015 to
shareholders of record at the close of business on December 31, 2014.
Conference Call Information
KPT will hold its third quarter conference call on Wednesday, November 12, 2014 at 8:30 a.m. Eastern Time.
Details of conference call:
Via telephone: 1-888-231-8191 or 647-427-7450
Via the internet at: www.kptissueinc.com
Presentation material referenced during the conference call will
be available at www.kptissueinc.com.
Conference Call Rebroadcast
A rebroadcast of the conference call will be available until
midnight, December 12, 2014 by
dialing 1-855-859-2056 or 416-849-0833 and entering passcode
2719340.
The replay of the webcast will remain available on the web site
until midnight, December 12,
2014.
About KP Tissue Inc. (KPT)
KPT was created to acquire, and its business is limited to holding,
a limited partnership interest in KPLP, which is accounted for as
an investment on the equity basis. KPT currently holds a 16.5%
interest in KPLP. For more information visit
www.kptissueinc.com.
About Kruger Products L.P. (KPLP)
KPLP is Canada's leading
manufacturer of quality tissue products for household, industrial
and commercial use. KPLP serves the Canadian consumer market with
such well-known brands as Cashmere®, Purex®, SpongeTowels®,
Scotties®' and White Swan®. In the U.S., KPLP manufactures the
White Cloud® brand, as well as many private label products. The
Away-From-Home division manufactures and distributes high-quality,
cost-effective product solutions to a wide range of commercial and
public entities. KPLP has approximately 2,500 employees across
North America and operates five
FSC® CoC- certified mills (FSC® C104904), four of which are located
in Canada and one in the US. For
more information visit www.krugerproducts.ca.
Non-IFRS Measures
This press release uses certain non-IFRS financial measures and
ratios which KPLP believes provide useful information to both
management of KPLP and the readers of the financial information in
measuring the financial performance and financial condition of
KPLP. These measures do not have a standardized meaning prescribed
by IFRS and therefore may not be comparable to similarly titled
measures presented by other companies. An example of such measures
is EBITDA. EBITDA is not a measurement of operating performance
computed in accordance with IFRS and should not be considered as a
substitute for operating income, net income or cash flows from
operating activities computed in accordance with IFRS. "EBITDA" is
calculated by KPLP as net income (loss) before (i) interest
expense, (ii) income taxes, (iii) depreciation,
(iv) amortization, (v) impairment of non-financial
assets, (vi) loss (gain) on disposal of property, plant and
equipment, (vii) unrealized foreign exchange loss (gain),
(viii) one-time costs related to restructuring activities, and
(ix) change in the amortized cost of the Partnership unit
liability. A reconciliation of EBITDA to the relevant reported
results can be found in the Management's Discussion and Analysis
("MD&A") of KPT and KPLP for the third quarter ended
September 28, 2014 available on SEDAR
at www.sedar.com.
Forward-Looking Statements
Certain statements in this press release about KPT's and KPLP's
current and future plans, expectations and intentions, results,
levels of activity, performance, goals or achievements or any other
future events or developments constitute forward-looking
statements. The words "may", "will", "would", "should", "could",
"expects", "plans", "intends", "trends", "indications",
"anticipates", "believes", "estimates", "predicts", "likely" or
"potential" or the negative or other variations of these words or
other comparable words or phrases, are intended to identify
forward-looking statements. The forward-looking information is
based on certain key expectations and assumptions made by KPT,
including expectations and assumptions concerning the impact of the
TAD Project on EBITDA. Although KPT believes that the expectations
and assumptions on which such forward-looking information is based
are reasonable, undue reliance should not be placed on the
forward-looking information since no assurance can be given that
such expectations and assumptions will prove to be correct.
Many factors could cause KPLP's actual results,
level of activity, performance or achievements or future events or
developments (which could in turn affect the economic benefits
derived from the Corporation's economic interest in KPLP) to differ
materially from those expressed or implied by the forward-looking
statements, including, without limitation, the following factors,
which are discussed in greater detail in the "Risk Factors - Risks
Related to KPLP's Business" section of the KPT Annual Information
Form dated March 19, 2014 available
on SEDAR at www.sedar.com: Kruger Inc.'s influence over KPLP;
KPLP's reliance on Kruger Inc.; consequences of an event of
insolvency relating to Kruger Inc.; risks associated with the TAD
Project; operational risks; Gatineau
Plant land lease; significant increases in prices; reduction
in supply of fibre; increased pricing pressure and intense
competition; KPLP's inability to innovate effectively; adverse
economic conditions; dependence on key retail trade customers;
damage to the reputation of KPLP or KPLP's brands; KPLP's sales
being less than anticipated; KPLP's failure to implement its
business and operating strategies; KPLP's obligation to make
regular capital expenditures; KPLP's entering into unsuccessful
acquisitions; KPLP's dependence on key personnel; KPLP's inability
to retain its existing customers or obtain new customers; KPLP's
loss of key suppliers; KPLP's failure to adequately protect its
intellectual property rights; KPLP's reliance on third party
intellectual property licenses; adverse litigation and other claims
affecting KPLP; material expenditures due to comprehensive
environmental regulation affecting KPLP's cash flow; KPLP's pension
obligations are significant and can be materially higher than
predicted if KPLP Management's underlying assumptions are
incorrect; labour disputes adversely affecting KPLP's cost
structure and KPLP's ability to run its plants; exchange rate and
U.S. competitors; KPLP's inability to service all of its
indebtedness; exposure to potential consumer product liability,
restrictive covenants; interest rate and refinancing risk;
information technology and innovation; insurance; and internal
controls.
Readers should not place undue reliance on
forward-looking statements made herein. The forward-looking
information contained herein is expressly qualified in its entirety
by this cautionary statement. The forward-looking information
contained herein is made as of the date of press release and KPT
undertakes no obligation to publicly update such forward-looking
information to reflect new information, subsequent or otherwise,
unless required by applicable securities laws.
Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Financial
Position
(thousands of Canadian dollars) |
|
|
September 28, 2014
$ |
|
December 31, 2013
$ |
Assets |
|
|
|
Current
assets |
|
|
|
|
Cash and cash equivalents |
36,339 |
|
87,674 |
|
Trade and other receivables |
108,386 |
|
94,789 |
|
Receivables from related parties |
789 |
|
1,429 |
|
Advances to partners |
2,432 |
|
- |
|
Inventories |
152,479 |
|
151,505 |
|
Current portion of income tax
recoverable |
745 |
|
630 |
|
Prepaid expenses |
7,644 |
|
4,777 |
|
308,814 |
|
340,804 |
Non-current
assets |
|
|
|
|
Property, plant & equipment |
635,903 |
|
616,687 |
|
Other long-term assets |
9,621 |
|
10,268 |
|
Income tax recoverable |
15,078 |
|
14,132 |
|
Goodwill |
160,842 |
|
152,021 |
|
Intangible assets |
13,993 |
|
13,483 |
|
Deferred income taxes |
18,732 |
|
14,141 |
Total assets |
1,162,983 |
|
1,161,536 |
|
|
|
|
Liabilities |
|
|
|
Current
liabilities |
|
|
|
|
Trade and other payables |
159,236 |
|
188,470 |
|
Payables to related parties |
5,397 |
|
5,134 |
|
Distributions payable |
9,600 |
|
9,455 |
|
Current portion of provisions |
1,946 |
|
999 |
|
Current portion of long-term
debt |
11,650 |
|
8,276 |
|
187,829 |
|
212,334 |
Non-current
liabilities |
|
|
|
|
Long-term debt |
354,941 |
|
342,013 |
|
Other long-term liabilities |
192 |
|
323 |
|
Provisions |
7,782 |
|
6,615 |
|
Pensions |
102,577 |
|
80,380 |
|
Post-retirement benefits |
53,312 |
|
48,746 |
|
Liabilities to
non-unitholders |
706,633 |
|
690,411 |
|
Current portion of Partnership units
liability |
3,475 |
|
3,475 |
|
Long-term portion of Partnership
units liability |
116,796 |
|
114,364 |
|
Total Partnership units
liability |
120,271 |
|
117,839 |
Total
liabilities |
826,904 |
|
808,250 |
|
|
|
|
Equity |
|
|
|
|
Partnership units |
295,422 |
|
282,672 |
|
Retained earnings |
8,270 |
|
50,945 |
|
Accumulated other comprehensive
income |
32,387 |
|
19,669 |
Total equity |
336,079 |
|
353,286 |
Total equity and
liabilities |
1,162,983 |
|
1,161,536 |
Kruger Products
L.P.
Unaudited Condensed Consolidated Statement of Comprehensive
Income
(thousands of Canadian dollars) |
|
|
|
|
|
|
|
|
|
13-week
period ended
September 28, 2014
$ |
|
13-week
period ended
September 29, 2013
$ |
|
39-week
period ended
September 28, 2014
$ |
|
39-week
period ended
September 29, 2013
$ |
|
|
|
|
|
|
|
|
Revenue |
267,629 |
|
243,848 |
|
767,521 |
|
712,402 |
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
|
|
Cost of sales |
219,914 |
|
200,811 |
|
645,137 |
|
585,611 |
|
Selling, general and administrative
expenses |
17,717 |
|
19,685 |
|
58,125 |
|
62,853 |
|
Recovery of non-financial assets |
- |
|
- |
|
- |
|
(1,789) |
|
Restructuring costs |
- |
|
- |
|
2,835 |
|
- |
|
|
|
|
|
|
|
|
Operating
income |
29,998 |
|
23,352 |
|
61,424 |
|
65,727 |
|
|
|
|
|
|
|
|
|
Interest expense |
12,622 |
|
11,403 |
|
34,923 |
|
32,300 |
|
Other (income) expense |
2,752 |
|
(899) |
|
7,622 |
|
1,824 |
|
|
|
|
|
|
|
|
Income before income
taxes |
14,624 |
|
12,848 |
|
18,879 |
|
31,603 |
|
|
|
|
|
|
|
|
Income taxes |
(1,477) |
|
(1,315) |
|
(2,118) |
|
(9,653) |
|
|
|
|
|
|
|
|
Net income for the
period |
16,101 |
|
14,163 |
|
20,997 |
|
41,256 |
|
|
|
|
|
|
|
|
Other comprehensive
income (loss) |
|
|
|
|
|
|
|
|
Items that will not be
reclassified to net income: |
|
|
|
|
|
|
|
|
Remeasurements of pensions |
(1,999) |
|
8,580 |
|
(31,511) |
|
42,278 |
|
Remeasurements of post-retirement
benefits |
(18) |
|
5 |
|
(3,511) |
|
1,509 |
|
Items that may be subsequently
reclassified to net income: |
|
|
|
|
|
|
|
|
Available-for-sale investment |
(183) |
|
78 |
|
(321) |
|
78 |
|
Cumulative translation
adjustment |
12,260 |
|
(5,506) |
|
13,039 |
|
7,868 |
|
|
|
|
|
|
|
|
|
Total other
comprehensive income (loss) for the period |
10,060 |
|
3,157 |
|
(22,304) |
|
51,733 |
|
|
|
|
|
|
|
|
Comprehensive income
(loss) for the period |
26,161 |
|
17,320 |
|
(1,307) |
|
92,989 |
Kruger Products
L.P.
Unaudited Condensed Consolidated Statement of Cash Flows
(thousands of Canadian dollars) |
|
|
|
|
|
|
|
|
|
13-week
period ended
September 28, 2014
$ |
|
13-week
period ended
September 29, 2013
$ |
|
39-week
period ended
September 28, 2014
$ |
|
39-week
period ended
September 29, 2013
$ |
Cash flows from (used
in) operating activities |
|
|
|
|
|
|
|
Net income for the
period |
16,101 |
|
14,163 |
|
20,997 |
|
41,256 |
Items not affecting
cash |
|
|
|
|
|
|
|
|
Depreciation |
8,380 |
|
7,675 |
|
26,574 |
|
23,864 |
|
Amortization |
148 |
|
139 |
|
479 |
|
415 |
|
Loss (gain) on sale of fixed
assets |
(577) |
|
- |
|
(279) |
|
(4) |
|
Change in amortized cost of
Partnership units liability |
1,043 |
|
- |
|
5,907 |
|
- |
|
Unrealized foreign exchange loss |
1,796 |
|
(927) |
|
1,879 |
|
1,566 |
|
Interest expense |
12,622 |
|
11,403 |
|
34,923 |
|
32,300 |
|
Pension and post retirement
benefits |
2,435 |
|
2,422 |
|
7,439 |
|
7,586 |
|
Provisions |
245 |
|
212 |
|
2,666 |
|
697 |
|
Income taxes |
(1,477) |
|
(1,315) |
|
(2,118) |
|
(9,653) |
|
Recovery of non-financial assets |
- |
|
- |
|
- |
|
(1,789) |
|
Total items not affecting cash |
24,615 |
|
19,609 |
|
77,470 |
|
54,982 |
|
|
|
|
|
|
|
|
Net change in non-cash
working capital |
(12,395) |
|
(885) |
|
(29,663) |
|
(45,101) |
Contributions to pension
and post-retirement benefit plans |
(4,043) |
|
(7,251) |
|
(20,260) |
|
(21,968) |
Provisions paid |
(247) |
|
(207) |
|
(1,084) |
|
(2,009) |
Income tax payments |
(736) |
|
(382) |
|
(1,622) |
|
(2,119) |
Net cash from (used
in) operating activities |
23,295 |
|
25,047 |
|
45,838 |
|
25,041 |
|
|
|
|
|
|
|
|
Cash flows from (used
in) investing activities |
|
|
|
|
|
|
|
Purchase of property,
plant & equipment |
(6,628) |
|
(3,964) |
|
(19,994) |
|
(11,554) |
Purchases of
through-air-dried (TAD) expansion |
(978) |
|
(4,294) |
|
(7,190) |
|
(33,067) |
Available-for-sale
investment |
- |
|
(836) |
|
- |
|
(836) |
Government grants
received |
- |
|
1,078 |
|
- |
|
1,078 |
Purchases of
software |
(221) |
|
(3) |
|
(989) |
|
(93) |
Proceeds on sale of
property, plant and equipment |
577 |
|
- |
|
578 |
|
4 |
Acqusition of business
(net) |
- |
|
- |
|
(23,360) |
|
- |
Net cash used in
investing activities |
(7,250) |
|
(8,019) |
|
(50,955) |
|
(44,468) |
Cash flows from (used
in) financing activities |
|
|
|
|
|
|
|
Proceeds from credit
facilities |
- |
|
6,242 |
|
- |
|
10,813 |
Repayment of credit
facilities |
(3,824) |
|
(366) |
|
(4,334) |
|
(4,096) |
Payment of deferred
financing fees |
- |
|
(159) |
|
- |
|
(612) |
Interest paid on credit
facilities |
(10,799) |
|
(7,210) |
|
(21,196) |
|
(21,181) |
Distributions and
advances |
(10,592) |
|
(9,367) |
|
(34,287) |
|
(20,599) |
Equity issuance
costs |
- |
|
(1,206) |
|
- |
|
(1,206) |
Proceeds from issuing
partnership units |
4,284 |
|
4,897 |
|
12,750 |
|
22,280 |
Net cash used in
financing activities |
(20,931) |
|
(7,169) |
|
(47,067) |
|
(14,601) |
Effect of exchange
rate changes on cash and cash equivalents held in foreign
currency |
741 |
|
(409) |
|
849 |
|
353 |
Decrease in cash and
cash equivalents during the period |
(4,145) |
|
9,450 |
|
(51,335) |
|
(33,675) |
Cash and cash
equivalents - Beginning of period |
40,484 |
|
78,364 |
|
87,674 |
|
121,489 |
Cash and cash
equivalents - End of period |
36,339 |
|
87,814 |
|
36,339 |
|
87,814 |
Kruger Products
L.P.
Segment and Geographic Results
(thousands of Canadian dollars) |
|
|
|
|
|
|
|
|
|
13-week
period ended
September 28, 2014
$ |
|
13-week
period ended
September 29, 2013
$ |
|
39-week
period ended
September 28, 2014
$ |
|
39-week
period ended
September 29, 2013
$ |
|
|
|
|
|
|
|
|
Segment
Information |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment
Revenue |
|
|
|
|
|
|
|
|
Consumer |
209,495 |
|
200,802 |
|
624,773 |
|
590,563 |
|
AFH |
52,613 |
|
40,321 |
|
130,359 |
|
115,606 |
|
Other |
5,521 |
|
2,725 |
|
12,389 |
|
6,233 |
Total segment
revenue |
267,629 |
|
243,848 |
|
767,521 |
|
712,402 |
|
|
|
|
|
|
|
|
Segment
EBITDA |
|
|
|
|
|
|
|
|
Consumer |
37,745 |
|
30,087 |
|
92,235 |
|
83,116 |
|
AFH |
1,767 |
|
1,193 |
|
1,380 |
|
5,333 |
|
Other |
(1,476) |
|
(142) |
|
(2,418) |
|
(494) |
Total segment EBITDA |
38,036 |
|
31,138 |
|
91,197 |
|
87,955 |
|
|
|
|
|
|
|
|
Reconciliation to Net
Income: |
|
|
|
|
|
|
|
Depreciation and
amortization |
8,528 |
|
7,814 |
|
27,053 |
|
24,279 |
Interest expense |
12,622 |
|
11,403 |
|
34,923 |
|
32,300 |
Change in amortized cost
of Partnership units liability |
1,043 |
|
- |
|
5,907 |
|
- |
Gain (loss) on sale of
fixed assets |
(577) |
|
- |
|
(279) |
|
(4) |
Recovery of non-financial
assets |
- |
|
- |
|
- |
|
(1,789) |
Restructuring costs |
- |
|
- |
|
2,835 |
|
- |
Unrealized foreign
exchange loss |
1,796 |
|
(927) |
|
1,879 |
|
1,566 |
Income before income
taxes |
14,624 |
|
12,848 |
|
18,879 |
|
31,603 |
Income taxes |
(1,477) |
|
(1,315) |
|
(2,118) |
|
(9,653) |
Net income for the
period |
16,101 |
|
14,163 |
|
20,997 |
|
41,256 |
|
|
|
|
|
|
|
|
Geographic
Revenue |
|
|
|
|
|
|
|
Canada |
182,260 |
|
175,290 |
|
516,401 |
|
515,939 |
U.S. |
77,758 |
|
62,170 |
|
230,826 |
|
175,635 |
Mexico |
7,611 |
|
6,388 |
|
20,294 |
|
20,828 |
Total Revenue |
267,629 |
|
243,848 |
|
767,521 |
|
712,402 |
KP Tissue Inc.
Unaudited Condensed Statement of Financial Position
(thousands of Canadian dollars) |
|
|
|
|
|
September 28, 2014
$ |
|
December 31, 2013
$ |
Assets |
|
|
|
|
|
|
|
Current
assets |
|
|
|
|
Distributions receivable |
1,593 |
|
1,583 |
|
Receivable from Partnership |
127 |
|
- |
|
1,720 |
|
1,583 |
Non-current
assets |
|
|
|
|
Investment in associate |
153,206 |
|
161,584 |
Total Assets |
154,926 |
|
163,167 |
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
Current
liabilities |
|
|
|
|
Dividend payable |
1,593 |
|
1,583 |
|
Payables to Partnership |
153 |
|
- |
|
Advances from Partnership |
409 |
|
- |
|
Income taxes payable |
433 |
|
580 |
|
2,588 |
|
2,163 |
Non-current
liabilities |
|
|
|
|
Deferred income taxes |
2,030 |
|
3,033 |
|
|
|
|
Total
liabilities |
4,618 |
|
5,196 |
|
|
|
|
Equity |
|
|
|
|
|
|
|
|
Common shares |
9,945 |
|
9,068 |
|
Contributed surplus |
144,819 |
|
144,819 |
|
Retained earnings (deficit) |
(10,245) |
|
709 |
|
Accumulated other comprehensive
income |
5,789 |
|
3,375 |
Total equity |
150,308 |
|
157,971 |
Total liabilities and
equity |
154,926 |
|
163,167 |
KP Tissue Inc.
Unaudited Condensed Statement of Comprehensive Income
(thousands of Canadian dollars, except share and per share
amounts) |
|
|
|
|
|
|
|
|
|
13-week
period ended
September 28, 2014
$ |
|
13-week
period ended
September 29, 2013
$ |
|
39-week
period ended
September 28, 2014
$ |
|
39-week
period ended
September 29, 2013
$ |
|
|
|
|
|
|
|
|
Equity income
(loss) |
1,235 |
|
1,016 |
|
(944) |
|
1,497 |
|
|
|
|
|
|
|
|
Gain on remeasurement
of over allotment option |
- |
|
- |
|
- |
|
375 |
Dilution gain |
37 |
|
69 |
|
95 |
|
181 |
Loss before income
taxes |
1,272 |
|
1,085 |
|
(849) |
|
2,053 |
|
|
|
|
|
|
|
|
Income tax expense
(recovery) |
|
|
|
|
|
|
|
Current |
791 |
|
293 |
|
872 |
|
892 |
Deferred |
(206) |
|
277 |
|
(454) |
|
737 |
|
585 |
|
570 |
|
418 |
|
1,629 |
Net income (loss) for
the period |
687 |
|
515 |
|
(1,267) |
|
424 |
|
|
|
|
|
|
|
|
Other comprehensive
income (loss) |
|
|
|
|
|
|
|
|
Items that will not be
reclassified to net loss: |
|
|
|
|
|
|
|
|
Remeasurements of pensions - net of
tax recovery |
(284) |
|
1,254 |
|
(4,564) |
|
6,186 |
|
Remeasurements of post-retirement
benefits - net of tax recovery |
(1) |
|
1 |
|
(356) |
|
221 |
|
Items that may be subsequently
reclassified to net loss: |
|
|
|
|
|
|
|
|
Available-for-sale investment - net
of tax recovery |
(26) |
|
- |
|
(47) |
|
- |
|
Cumulative translation adjustment -
net of tax expense |
2,309 |
|
(807) |
|
2,461 |
|
1,150 |
Total other
comprehensive income (loss) for the period |
1,998 |
|
448 |
|
(2,506) |
|
7,557 |
Comprehensive income
(loss) for the period |
2,685 |
|
963 |
|
(3,773) |
|
7,981 |
Basic earnings (loss)
per share |
0.08 |
|
0.06 |
|
(0.14) |
|
0.05 |
Weighted average
number of shares outstanding |
8,845,503 |
|
8,781,433 |
|
8,825,759 |
|
8,739,702 |
KP Tissue Inc.
Unaudited Condensed Statement of Cash Flows
(thousands of Canadian dollars) |
|
|
|
|
|
|
|
|
|
13-week
period ended
September 28, 2014
$ |
|
13-week
period ended
September 29, 2013
$ |
|
39-week
period ended
September 28, 2014
$ |
|
39-week
period ended
September 29, 2013
$ |
Cash flows from (used
in) operating activities |
|
|
|
|
|
|
|
Net income (loss) for the
period |
687 |
|
515 |
|
(1,267) |
|
424 |
Items not affecting
cash |
|
|
|
|
|
|
|
|
Equity loss (income) |
(1,235) |
|
(1,016) |
|
944 |
|
(1,497) |
|
Gain on remeasurement of
overallotment option |
- |
|
- |
|
- |
|
(375) |
|
Dilution gain |
(37) |
|
(69) |
|
(95) |
|
(181) |
|
Income taxes |
585 |
|
570 |
|
418 |
|
1,629 |
|
Total items not affecting cash |
(687) |
|
(515) |
|
1,267 |
|
(424) |
Income tax payments |
(175) |
|
- |
|
(868) |
|
- |
Net cash from (used
in) operating activities |
(175) |
|
- |
|
(868) |
|
- |
|
|
|
|
|
|
|
|
Cash flows from (used
in) investing activites |
|
|
|
|
|
|
|
Investment in
associate |
(303) |
|
(150) |
|
(877) |
|
(13,719) |
Partnership unit
distributions received |
1,589 |
|
1,579 |
|
4,757 |
|
3,477 |
Tax distributions
received |
- |
|
- |
|
459 |
|
- |
Advances received |
175 |
|
- |
|
409 |
|
- |
Net cash from (used
in) investing activities |
1,461 |
|
1,429 |
|
4,748 |
|
(10,242) |
|
|
|
|
|
|
|
|
Cash flows from (used
in) financing activities |
|
|
|
|
|
|
|
Issuance of common
shares |
303 |
|
150 |
|
877 |
|
13,719 |
Dividends paid |
(1,589) |
|
(1,579) |
|
(4,757) |
|
(3,477) |
Net cash from (used
in) financing activities |
(1,286) |
|
(1,429) |
|
(3,880) |
|
10,242 |
Increase (decrease) in
cash and cash equivalents during the period |
- |
|
- |
|
- |
|
- |
Cash and cash
equivalents - Beginning of period |
- |
|
- |
|
- |
|
- |
Cash and cash
equivalents - End of period |
- |
|
- |
|
- |
|
- |
SOURCE KP Tissue Inc.